Get the Weekly Intelligence Brief — top committee picks every Sunday.
WAT · NASDAQ · STOCK

Waters Corporation

Healthcare Updated August 09, 2026
$411.10
52W $278.49 – $414.15
70/100
$30.43B
101.2
1.19
AI Committee Verdict
Buy
70/100
Conviction: High · 75% agreement · 4 analysts
+0.2%
-29.4%
0.01:1
High
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is WAT Bullish or Bearish?

Bullish. Innellis AI committee rates Waters Corporation (WAT) Buy with a composite score of 70/100 , based on 4 analysts with 75% agreement. Last updated August 09, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +5.45 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -14.55 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 75 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull & Bear Case

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.27 across 29 articles, 14d) — News
Bear Case
  • RSI at 75 is in overbought territory — Technical
  • Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 09, 2026
Overall Committee Score
70/100
Agreement
75%
Analysts
4
Conviction
High
Sector Rank
Top 6%
of 95 Healthcare peers
Growth Analyst bullish
85 / 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst neutral
57 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− RSI at 75 is in overbought territory
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
66 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 29 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 70.1 to 69.5.

Analyst-level changes:
  • News Analyst: +1 bullish signal(s).

Comparing 2026-08-08 to 2026-08-09 (1 day apart).

Technical Analysis

RSI (14)
75.0
Overbought
MACD Histogram
2.809
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$287.28
Resistance
$407.75
Bollinger %B
1.05
Above Upper Band
Price vs Moving Averages
EMA 9
$391.39 Above
EMA 21
$382.71 Above
EMA 50
$370.96 Above
EMA 200
$347.82 Above

Fundamental Analysis

Valuation
67
Growth
66
Profitability
74
Financial Health
50
Cash Flow
70
Valuation
P/E Ratio 101.2×
P/B Ratio 0.00×
PEG Ratio -1.58
Dividend Yield 0.00%
52W High $414.15
52W Low $278.49
Quality & Growth
ROE 2509.0%
ROA 1265.9%
Gross Margin 5078.3%
Operating Margin 796.0%
Revenue Growth YoY
Debt / Equity 0.33
AI Fundamental Assessment
P/E ratio of 101.2 (rich relative to a 15-40x range); Price-to-book of 0.0x; PEG ratio of -1.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 25.1%; Return on assets of 12.7%; Net margin of 3.6%; Gross margin of 50.8%; Current ratio of 0.00 (tight short-term liquidity); Debt-to-equity of 0.33; Free cash flow per share is positive (4037.02); Most recent quarter beat estimates by 0.4%; 2 consecutive earnings beats; EPS growth accelerating (-40.4% -> +13.0% QoQ); Average YoY EPS growth of 3.4%; Analyst estimates falling over recent quarters
Get the Full WAT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore WAT Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime